⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0002109299

Bhalla Narinder Pal

Reports to the SEC for 1 company · NEW YORK, NY

Transactions

6

Companies

1

Filings

3

CIK

0002109299

Forms 4 and 5

Insider transactions

6 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-24	LXEOLexeo Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+54.8K sh	—	—	54,750
2026-09-14	LXEOLexeo Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+2,714 sh	$3.58	+$9,713.406	84,908
2026-07-01	LXEOLexeo Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−22.3K sh	$4.42	−$98.6K	82,194
2026-06-29	LXEOLexeo Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+55K sh	—	—	104,500
2026-02-13	LXEOLexeo Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+49.5K sh	—	—	49,500
2026-02-13	LXEOLexeo Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+297K sh	—	—	297,000

Recent filings

3

Accepted (ET)
Sep 284
Bhalla Narinder Pal0002109299-26-000009
SEC(opens sec.gov)
Jul 14
Bhalla Narinder Pal0002109299-26-000007
SEC(opens sec.gov)
Feb 174
Bhalla Narinder Pal0002109299-26-000004
SEC(opens sec.gov)

Companies

1

Lexeo Therapeutics, Inc.Chief Medical OfficerLXEO

Address

C/O LEXEO THERAPEUTICS, INC. 345 PARK AVENUE SOUTH, 6TH FLOOR

NEW YORK, NY, 10010